Atlas Trials

Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration

Clinical trial NCT00457444 · COMPLETED

Trial details

NCT number
NCT00457444
Sponsor
University of Zurich
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rhinoconjunctivitis
Start date
2005-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.